In the original article, we neglected to include the funder “US Department of Defense Threat Reduction Agency grant H.10016_09_AR_R to SG, administered by The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.”
In the original article, we missed mentioning that we also used GT3 from American River Nutrition (Hadley, MA, United States). A correction has been made to Materials and Methods, GT3 Formulation:
“Pure GT3 was obtained from Yasoo Health Inc. (Johnson City, TN, United States) (Ghosh et al., 2009) and American River Nutrition (Hadley, MA, United States). GT3 and Tween80® (final concentration 5%) were dissolved separately in small volume of ethanol (to enable uniform mixing) and mixed together and then spin-dried under vacuum. Required volume of saline was added to the tube to achieve a final concentration of either 100 or 200 mg GT3 in 0.1 ml.”
Furthermore, we missed acknowledging Dr. Kushal Chakraborty, and missed mentioning the funding agency US Department of Defense Threat Reduction Agency grant H.10016_09_AR_R. A correction has been made to Acknowledgements:
“The authors gratefully acknowledge pathologists LTC Culp (USUHS) for histopathological evaluations of slides, the dosimetrists and SARRP operators Sungyop Kim and Dr. David A. Schauer, Kefale Wuddie and Zemenu Aschenake for animal care and manipulations, Dr. Kushal Chakraborty and Betre Legesse for technical assistance, and Anne Trias (American River Nutrition) for providing GT3. The opinions and assertions expressed herein are those of the authors and do not necessarily reflect the official policy or position of the Uniformed Services University or the Department of Defense.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
gamma tocotrienol, partial body irradiation, lung injury, SARRP, small animal radiation research platform, radiation injury to normal lungs, prophylactic treatment, thoracic irradiation
Citation
Kumar VP, Stone S, Biswas S, Sharma N and Ghosh SP (2021) Corrigendum: Gamma Tocotrienol Protects Mice From Targeted Thoracic Radiation Injury. Front. Pharmacol. 12:785165. doi: 10.3389/fphar.2021.785165
Received
28 September 2021
Accepted
21 October 2021
Published
29 November 2021
Volume
12 - 2021
Edited and reviewed by
Alastair George Stewart, The University of Melbourne, Australia
Updates
Copyright
© 2021 Kumar, Stone, Biswas, Sharma and Ghosh.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Vidya P. Kumar, vidya.kumar.ctr@usuhs.edu; Sanchita P. Ghosh, sanchita.ghosh@usuhs.edu
This article was submitted to Translational Pharmacology, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.